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ABSTRACT
This article presents the new German law on advance
directives from 1 September 2009. The history of the
parliamentary process of this law is described, the
present regulations are explained, their relevance for
medical practice discussed and shortcomings are
identified. Finally, the new law is compared with other
regulations in the international context. Previously
established legal practice in Germany has now become
largely confirmed by the new law: An advanced directive
must be respected in any decision concerning medical
treatment, regardless of the stage of the illness. It can
be informally revoked at any time, even with limited
decision-making capacity. Nobody may be obliged to
issue a directive in any way. Advance directives do not
need notarisation or routine updating after certain time
intervals. Provided that the patient, who is no longer
mentally competent, has issued a lasting power of
attorney (Bevollma¨chtiger), or provided that the patient
has been appointed a healthcare proxy by the courts
(Betreuer), this authorised surrogate must assert the
patient’s will. The role of the guardianship court is
clarified: it only needs to be involved in cases of
disagreement as to the patient’s will. The new German
law thus combines more legal certainty with a liberal
emphasis on patient autonomy and flexible, adaptable
regulations.
Medical decision-making at the end of life is
frequently complicated by the fact that patients
lose the capacity to decide about their treatment. In
advance directives, patients can anticipate future
medical situations and document prospectively
how they want to be treated in these situations. As
a considerable and increasing proportion of patients
in Europe use advance directives,1 2 the legislators
in many European countries have seen the need to
clarify this issue in statutory laws.3 4 The European
Convention on Human Rights and Biomedicine
from 1997 includes a statement that previously
expressed treatment wishes of patients are to be
taken into account,5 and recently the Council of
Europe has issued recommendations on principles
concerning advance directives to its member
states.6 Germany has now followed many neigh-
bour countries in Europe and introduced a law on
advance directives.7 We will present the regulations,
discuss their relevance for medical practice, identify
shortcomings and comment on the new law in the
international context.
NEED TO REFORM THE LAW
Advance directives have become increasingly
important in recent years in Germany. More and
more Germans complete such documents, and the
German Medical Association has granted them
a greater role in medical decision-making. Never-
theless, no statutory law has been regulating
advance directives. Authoritative case law and
ethical guidelines by the German Medical Associa-
tion have offered some orientation for healthcare
professionals and the general public.
Yet judicial decisions were often inconsistent and
fell short of providing an unequivocal clarification
of the law on advance directives. This was espe-
cially true for a technically faulty judgement of the
Federal Court from 17 March 2003, which,
although establishing the binding nature of
advance directives, included contradictory state-
ments in a series of essential points.8 What
remained disputed after the judgement were, in
particular, questions concerning the scope of
advance directives and the role of the guardianship
court: was the validity of advance directives
restricted to situations in which patients were in
the terminal stages of incurable diseases? Was there
an obligation to obtain court approval for all cases
of treatment withdrawal or withholding on the
basis of advance directives or only if there was
disagreement between the parties involved?
Consequently, the then minister of justice,
Brigitte Zypries, instituted a working group called
‘Patient Autonomy at the End of Life’ that
presented the outline of a law on advance directives
in June 2004.9 This report formed the basis of
a draft bill written by a cross-party group of
members of parliament (MPs), led by the Social
Democrat, Joachim Stünker.10 It emphasised the
right of patient self-determination and represented
a liberal interpretation of the hitherto existing case
law.
An opposing bill, authored by a cross-party group
around the conservative Christian Democrat MP,
Wolfgang Bosbach, limited the bindingness of
advance directives to illnesses with an ‘irreversible
fatal progression’. It also placed high formal hurdles
in front of the directives, such as requiring
authorised notarisation. A third bill, introduced by
Wolfgang Zöller, an MP of the Christian Social
Union, emphasised the dialogue between relatives
and physicians before implementing an advance
directive, but did not include any restriction
regarding the patient’s kind of illness.
After a failed attempt to merge the Stünker and
Zöller bills, the Stünker group incorporated two
core principles of the Zöller draft shortly before the
vote in the federal parliament (Bundestag). These
amendments emphasised the role of the medical
indication in end-of-life decision-making and the
importance of dialogue and communication in
implementing advance directives. After lifting the
restriction of voting along party lines, the law was
passed with votes from the majority of the Social
Democrats, the Liberal Democrats, the MPs from
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the Leftist Party, a group of Green Party MPs, but only one MP of
the Christian Democratic and Christian Social Unions. The law
became effective on 1 September 2009. The voting behaviour is
noteworthy in three regards: (1) after a parliamentary debate
over two legislative periods and numerous voices to withdraw
legislation on this issue, it is surprising that there was actually
a law passed in the end; (2) the German Bundestag has recently
voted far more conservatively on biopolitical issues (eg, genetic
engineering law, stem cell law, embryonic protection law); (3)
although the German MPs were officially liberated from party
whip, the parties did in fact vote rather corporately.
THE NEW LEGAL SITUATION
The new German law is oriented along previous judicial deci-
sions. A written advance directive authored by a mentally
competent patient for the event of future incompetence is now
legally binding according to x1901a.1 of the German Civil Code
(Bürgerliches Gesetzbuch, BGB). This binding directive must be
respected in any decision concerning medical treatment,
regardless of the stage of illness (x1901a.3 BGB). Provided that
the patient, who is no longer mentally competent, has issued
a lasting power of attorney (Bevollmächtiger), or provided that
the patient has been appointed a healthcare proxy by the courts
(Betreuer), this authorised surrogate must assert the patient’s
will vis-à-vis the physician, the nurses and the institutions in
which the patient is being treated. When no written advance
directive exists, the treatment preferences or the patient’s
presumed will must be determined based on concrete evidence,
such as previous oral statements (x1901a.2 BGB).
What the patient’s will might be in concrete terms and
whether the situation at hand corresponds with the situation
that was mentioned in the advanced directive must be deter-
mined in a communication process between the physician and
the patient’s surrogate, whereas the physician has to determine
the medical indication in advance (x1901b BGB). Approval
by the adult guardianship court is not necessary if the physician
and the surrogate agree on the patient’s will in a concrete situ-
ation (x1904 BGB).
The law states that advance directives are only valid in
writing. According to x126 of the German Civil Code, a written
statement must always be signed by hand; this formal require-
ment is also satisfied by the often-used checkbox forms as long
as it includes the patient’s signature. Notarisation is not neces-
sary. A verbal statement, although not recognised as an advance
directive, is still of legal value. In determining a patient’s will,
a verbal statement is recognised either as an expression of
preferred treatment, when referring directly to a specific treat-
ment in question, or as a clear sign of the presumed will of the
patient. The law also makes explicit that only an adult (18 years
or above) can establish an advance directive.
In line with traditional guardianship law, the new law does
not explicitly refer to the binding nature of advance directives,
but rather presupposes it.10 As the advance directive is regarded
as binding, the authorised surrogate must abide by it and ensure
that it is implemented by doctors, nurses and institutions.
An advance directive that is clearly applicable to the circum-
stances of a case can be followed directly by the physician even
when there is no surrogate that represents the patient as deci-
sion-maker. Due to the principle of necessity in guardianship law
(x1896.2 BGB), a proxy does not have to be named in such
a situation, as he or she is not needed to implement the patient’s
will. The attending physician, however, has to be certain that
the advance directive accurately matches the situation.
The law, as spelled out in x1901b BGB, intends that the
physician, after examining the medical indication, will deter-
mine the patient’s will in close communication with the
patient’s surrogate and, if time allows, by enlisting the aid of
‘close relatives and other persons the patient trusted’. This
procedure will especially serve to safeguard the decision-making
process and protect the physician and surrogate in ambiguous
cases. Those not abiding by the procedure will risk misinter-
preting the situation and then paying the legal consequences if
in hindsight another reading of the advance directive is deemed
more appropriate. Therefore, the higher the level of uncertainty
regarding the patient’s will, the higher the level of care that is
needed in guiding and documenting the dialogue between the
participating individuals.
MEDICAL INDICATION
The most important legal prerequisites for performing any
medical treatment are the medical indication and the patient’s
informed consent. The physician will first evaluate the medical
indication for a specific treatment for the individual patient in
the specific situation, based on scientific evidence and the state
of the art. The physician must decide whether the treatment in
question represents a benefit to the patient that outweighs the
risks and disadvantages. The following two questions must be
addressed: (1) What is the intended goal of the treatment under
discussion? (2) Is there a realistic probability that the intended
goal will be attained using this treatment?
As for the first question, every medical procedure must serve
a reasonable treatment goal in the first place. Examples of
generally accepted treatment goals include healing, prolongation
of life, rehabilitation or maintenance of quality of life. If no
reasonable treatment goal is available, such as when all possible
measures would only marginally prolong the process of dying,
the medical procedure in question is not warranted and should
not be carried out.
As for the second question, assuming a reasonable treatment
goal has been identified, the physician must decide whether,
according to existing evidence, there is a realistic chance that the
planned medical action will achieve this goal. Any measure that
cannot or in all likelihood will not achieve the intended goal is
not warranted (eg, artificial nutrition and hydration in advanced
dementia).11
INDICATION AND THE PATIENT’S WILL
It is only when the medical indication has been affirmed or at
least accepted with sufficient probability that the attending
physician will inform the patient or the patient’s representative
about the indicated treatment and seek informed consent for it by
clarifying the patient’s will (figure 1). Eliciting the patient’s will
and establishing a surrogate are superfluous if a medical indica-
tion is lacking. Conversely, no medical procedure, even though it
may be clearly indicated, can be performed against the patient’s
will (eg, blood transfusions for Jehovah’s Witnesses). If a decision
is based on the lack of medical indication, this can prevent
emotional burden for family members arising from the idea that
they may be responsible for the death of their loved one.12
Communicating the lack of a medical indication for life-
sustaining treatment and the necessity to redirect the treatment
goal from a curative to a palliative one represents a huge chal-
lenge for any physician. It is a challenge that should be met with
care, empathy, and an emphasis on the variety of palliative
treatments that are available to reduce suffering at the end of
life.
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The flow chart in figure 2 offers practical assistance on how
best to implement the German law on advance directives. As
a first step, the physician evaluates the medical indication for
the treatment in question. If the treatment is indicated, the
physician then determines whether the patient has decision-
making capacity. This is the case if the patient is able to
comprehend the scope and consequences of the proposed treat-
ment and to form a voluntary decision on the basis of his
personal values (decision-making capacity is different from the
legal capacity for affairs). In cases of doubt, a psychiatrist or
neurologist should be consulted.
The patient who possesses decision-making capacity will be
informed on the benefit and risks of the planned treatment as
well as on alternative measures. If the decision is difficult, it is
recommended to include, with the patient’s consent, the next of
kin into the dialogue. Before starting or stopping the treatment,
the decision should be thoroughly documented. In the event
that the patient lacks decision-making capacity, the physician
must first interpret any existing advance directive in cooperation
with the patient’s surrogate (if present) and the patient’s family.
If there is an advance directive that is clearly applicable to the
clinical situation at hand, the physician must treat the patient
according to the anticipatorily expressed will, unless concrete
information is available that the patient had revoked the direc-
tive in the meantime.
If there is no advance directive or the directive does not fit the
situation at hand, the physician should ascertain whether the
patient has a legally authorised surrogate. If this is not the case
and the clinical situation is acute, then the physician should seek
consensus with the patient’s family over the patient’s presumed
will and act accordingly. If time does not allow a consensus in an
emergency situation, the medically indicated treatment should
be performed. If there is sufficient time and no imminent danger,
the court should be asked to appoint a guardian who will then
be a legally authorised representative of the patient.
After a guardian has been appointed, the patient’s will is to be
determined and documented in a dialogue-based process.
Subsequent approval of the guardianship court is only necessary
if the physician and surrogate disagree on the patient’s will.
Their views as to what might be better or worse for the patient’s
wellbeing are legally irrelevant as the only guidance must be the
patient’s will. Here, German law is much more oriented towards
the principle of autonomy (patient’s will) than beneficence
(patient’s best interest). However, some scholars even dispute
the possibility that there might be a ‘best interest’ in conflict
with the patient’s will.13
When the decision is made to administer a certain treatment,
the physician is obliged to check continually throughout the
course of treatment whether the indication further persists.
Particularly at the end of life, indications for such procedures as
blood transfusion, corticosteroids or artificial nutrition may
change.
A LACK OF MEDICAL COUNSELLING
Previously established legal practice in Germany has now
become largely confirmed by the new law. The much debated
question whether to limit advance directives to terminal diseases
has been negated. The role of guardianship courts has been
clarified. Several points are now explicitly regulated: An advance
directive can be informally revoked at any time, even with
limited decision-making capacity. Hospitals and nursing homes
are not permitted to require advance directives as prerequisites
for admission, as nobody may be obliged to issue a directive in
any way. Advance directives do not need notarisation or routine
updating after certain time intervals. The new German law thus
combines more legal certainty with a liberal emphasis on patient
autonomy and flexible, adaptable regulations. Nevertheless,
ambiguities, points of criticism and recommendations for
improvements should be considered.
According to the law, the physician has to determine ‘which
medical procedure, in view of the overall condition and prognosis
of the patient, is indicated’ (x1901b BGB). Why does the law
explicate what doctors should be doing at least since the writings
of Hippocrates, namely to determine the individual medical
indication on the basis of prognosis? It seems that doctors have
not always observed this fundamental principle in their work.
Apparently they have sometimes focused on the technically
feasible rather than the individually indicated treatment.
The law does not specify how to solve cases of disagreement
over the medical indication. Indications are most often not
mathematically determined; they are a matter of judgement by
the physician, but what happens if the surrogate or a family
member questions the indication? The law does not specify
whether a second opinion should be sought. It is recommendable
that physicians themselves present this possibility as a means of
strengthening the trust relationship between the involved
parties.
The law does not require counselling before writing an advance
directive. An advance directive is ultimately a form of instruction
by a patient to his future physician concerning medical proce-
dures.14 Would it therefore not be completely sensible to seek
medical counselling before writing an advance directive? During
the drafting and legislative passage of the law, it was articulated
that lay organisations may offer competent counselling. It is
important to point out that non-medical professionals may
counsel patients regarding their values and attitudes, but they are
not in a position to offer advice on medical details. Medical facts
must be addressed when formulating an advance directive,
especially when the progression of an illness is foreseeable. For
this reason, medical counselling before completion of advance
directives is more than just desirable and needs to be included into
the service and benefits catalogue of health insurance companies.
MINORS
The jurisdiction has long recognised that minors may individu-
ally have the necessary capacity to consent to certain forms of
treatment. What does this mean with regard to advance direc-
tives? Oddly enough, the law requires authors of advance
directives to be adult (18 years or more), but does not comment
on the problem of minors with decision-making capacity. It is,
however, a general principle of German law that parents have to
respect the growing capability and interest of their children to
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Figure 1 The patient’s will: central criterion of medical decision making.
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participate in decision-making concerning their welfare. There-
fore, the expressed will of children and adolescents is to be
considered when parents make healthcare decisions for them.
Whether a well-reflected rejection of life-sustaining treatment by
a thoroughly informed teenager can be overruled by the parents
has yet to be determined in court. In any case, the role of the
physician is to try the utmost to bring about consensus among
family members in such situations to avoid complicated grieving
processes.15
From the medical as well as legal point of view, it is recom-
mended to combine an advance directive with a lasting power of
attorney.14 16 Clinical experience suggests that an authorised
representative alone can better represent the interests of the
patient than an advance directive alone without a surrogate
decision-maker.
GERMAN LAW IN THE EUROPEAN CONTEXT
Altogether, the new legal regulations in Germany harmonise
well with the laws that other European countries have intro-
duced recently.4 17 All of them affirm that an advance directive is
in general a legally binding documentation of the patient’s will.
Although Germany is notorious for having meticulous legal
regulations, this law is rather sketchy: it eschews many
controversial issues like, for example, the decision-making
capacity, the revocation of directives, the treatment of minors or
advance care counselling. Compared with the German law, an
example of a comprehensive and detailed statute is the English
Mental Capacity Act 2005.17 18 In the international context the
German law is quite liberal in that it does not stipulate many
requirements for advance directives to be legally binding.
Germany’s neighbour Austria, for example, requires patients to
get medical counselling and judicial testimony every 5 years if
they want to have a legally binding form of advance directive (as
opposed to a non-binding one that has to be taken into account
when determining the presumed will of the patient).19 More-
over, the German law is quite unique in emphasising the
authority of the medical indication as judged by the physician,
thus opening the way for end-of-life decisions based on futility.
An example for a very different way of dealing with the legal
questions posed by advance decision-making can be found in
Figure 2 Flow chart illustrating the
recommended decision-making process
when having to decide on medical
procedures (diagnostic or therapeutic).
Should a certain medical 
procedure be performed?
Is it 
medically
no
Withhold or withdraw 
Is the patient 
competent? 
yes
indicated?
yes
the medical procedure
no
Interpret the patient‘s
Applicable 
advance 
directive?
yes
no
Identify the 
patient`s will 
Is there a legal 
surrogate?
Explore the patient‘s 
will (physician, 
surrogate, relatives)
Emergency
situation?
Ask court to Explore the 
patient‘s will
yes
no
no
yes
anticipatory will
(physician, surrogate,
relatives)
(physician, patient, 
possibly relatives)
appoint a guardian
(physician, relatives)
Consensus?Perform the medically indicated procedure
no*
Consensus?
Document and treat 
according to the patient‘ will
Review by the 
guardianship court
yes
yes
no
Regularly review the medical indication
*or impossible due to time 
constraints (emergency cases)
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Italy, where one of the two chambers of parliament (the Senate)
has already passed a bill that would render advance directives
explicitly non-binding for the physician and would exclude
artificial nutrition and hydration ‘in any form’ from the treat-
ments that can be refused by the patients in an advance direc-
tive. The bill, which has been strongly endorsed by the Vatican,
has been sharply criticised by the Italian Society for Palliative
Care as a measure that would oblige physicians to practise
contrary to the patients’ best interests. The final legislative
outcome of the bill is unclear at present.20
CONCLUSIONS
With the new German law on end-of-life decisions, legal
certainty has been attained with regard to the binding nature of
advance directives. Specific questions still need to be addressed.
What appears paramount is avoiding an unnecessary legalism in
the doctorepatient relationship at the end of life. Therefore it is
to be welcomed that, according to the new law, the guardianship
court only needs to be involved in cases of disagreement as to
the patient’s will. Just as important is the clarification that,
when medical indication is lacking or when an unambiguous
advance directive is available, the appointment of a legal
guardian is unnecessary.
The goal of medicine at the end of life should always be to
view the patient and family as a unit of care, to respect the
patient autonomy and at the same time to shape decision-
making and communication in a manner that does not lead to
additional suffering for the family during the period of
mourning. The new German law offers an appropriate legal
framework for this goal but now needs to be disseminated to
and implemented by all healthcare professionals involved in
end-of-life care.
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